Zobrazeno 1 - 10
of 303
pro vyhledávání: '"Paul J. Nestel"'
Autor:
Graeme I. Lancaster, Denis Sviridov, Nigora Mukhamedova, Takahiro Kameda, Gerard Pernes, Peter J. Meikle, Ryunosuke Ohkawa, Boris L. Vaisman, Andrew J. Murphy, Ayuko Hara, Ying Fu, Michael Ditiatkovski, Shao-Jui Lai, Paul J. Nestel, Alan T. Remaley, Hann Low, Dmitri Sviridov, Minoru Tozuka, Yuna Horiuchi, Mai Sasaoka, Azusa Yamazaki
Publikováno v:
Journal of Lipid Research, Vol 61, Iss 12, Pp 1577-1588 (2020)
J Lipid Res
J Lipid Res
Lipoproteins play a key role in transport of cholesterol to and from tissues. Recent studies have also demonstrated that red blood cells (RBCs), which carry large quantities of free cholesterol in their membrane, play an important role in reverse cho
Publikováno v:
Current Opinion in Endocrinology, Diabetes & Obesity. 28:134-141
PURPOSE OF REVIEW Recent changes or confirmations linking patterns of eating and specific dietary interventions in the management of cardiovascular risk factors including associations with prevalent and incident type 2 diabetes. RECENT FINDINGS Recen
Publikováno v:
Current Opinion in Lipidology. 31:313-323
Purpose of review We have focused on recent research relevant to effects of dietary patterns and major food groups on cardiovascular outcomes, taking into account guidelines and position statements from expert authorities, with an emphasis on importa
Autor:
Adam Alexander T. Smith, Man K.S. Lee, Michelle Cinel, Bronwyn A. Kingwell, Sudip Paul, Paul J. Nestel, Kevin Culham, Natalie A. Mellett, Kaushala S. Jayawardana, Kevin A. Gunawan, Peter J. Meikle, Jacqueline M. Weir, Graeme I. Lancaster, Andrew J. Murphy
Publikováno v:
Journal of Lipid Research
Journal of Lipid Research, Vol 62, Iss, Pp 100092-(2021)
Journal of Lipid Research, Vol 62, Iss, Pp 100092-(2021)
Plasmalogens are membrane glycerophospholipids with diverse biological functions. Reduced plasmalogen levels have been observed in metabolic diseases; hence, increasing their levels might be beneficial in ameliorating these conditions. Shark liver oi
Autor:
Terje R. Pedersen, Gregory G. Schwartz, Andrew Tonkin, Anastasia Lesogor, Helen M. Colhoun, Christiane Drechsler, Florian Kronenberg, Peter Willeit, John Simes, Paul M. Ridker, Sotirios Tsimikas, Anders G. Olsson, Samia Mora, Paul J. Nestel, Christoph Wanner
Publikováno v:
Willeit, P, Ridker, P M, Nestel, P J, Simes, J, Tonkin, A M, Pedersen, T R, Schwartz, G G, Olsson, A G, Colhoun, H M, Kronenberg, F, Drechsler, C, Wanner, C, Mora, S, Lesogor, A & Tsimikas, S 2018, ' Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events : individual patient-data meta-analysis of statin outcome trials ', The Lancet, vol. 392, no. 10155, pp. 1311-1320 . https://doi.org/10.1016/S0140-6736(18)31652-0
BACKGROUND: Elevated lipoprotein(a) is a genetic risk factor for cardiovascular disease in general population studies. However, its contribution to risk for cardiovascular events in patients with established cardiovascular disease or on statin therap
This dietary guidance, informed by best contemporary evidence, aims to assist medical practitioners and allied health professionals in advising patients for the primary and secondary prevention of cardiovascular disease (CVD). While differing in some
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc04e532921758bcc0ea8fb3f15613fd
https://hdl.handle.net/11541.2/146276
https://hdl.handle.net/11541.2/146276
Autor:
Nicholas Pachter, Annette Pedrotti, Allison C Morton, Michael M. Page, David R. Sullivan, Ann Marie Woodward, Amanda J Hooper, Stjepana Maticevic, Luke Elias, Peter M Clifton, Shubha Srinivasan, Zanfina Ademi, Natalie C Ward, Gemma A. Figtree, Christian R Hamilton-Craig, Christina A Bursill, Kathryn E Waddell-Smith, Trevor A Mori, John R Burnett, Catherine Spinks, Elif I Ekinci, John Irvin, Jing Pang, Sam Mirzaee, Ronald J. Trent, Peter Brett, Carl J Schultz, Paul Lacaze, Anthony C Keech, David M Colquhoun, Russell S Scott, Ari Horton, Ingrid Winship, Justin J Ardill, Gerald F. Watts, Nicola K. Poplawski, Peter J Psaltis, Edward D Janus, Charlotte Hespe, Andrew Wilson, Christopher Semsarian, Joanna C Moullin, Jan Radford, Jacqueline Dm Ryan, Jacquie Garton-Smith, Clara K Chow, Frank van Bockxmeer, Clare Heal, Alex Brown, Stephen J. Nicholls, Stephen Ch Li, Dorothy F Graham, Andrew B Kirke, David L Hare, Lawrence J Beilin, Timothy R Bates, Brett H Forge, Nadarajah Kangaharan, Laurence G. Howes, Leon A Simons, Tom Brett, Damon A. Bell, Elizabeth N Robertson, Mitchell Sarkies, Warrick Bishop, Robert N. Justo, Nicola J Reid, Jodie Ingles, Paul J. Nestel, Harvey D White, Wendy Barnett, Richard C O'Brien, Kirsten Lambert, Karam Kostner, Campbell V Kyle, J Andrew Black, Alison Colley, Ian Hamilton-Craig, Brendan M McQuillan, W. L. Malan, Andrew Tonkin, Kristen J. Nowak, Leonard Kritharides, Andrew J. Martin
Publikováno v:
Am J Prev Cardiol
American Journal of Preventive Cardiology, Vol 6, Iss, Pp 100151-(2021)
American Journal of Preventive Cardiology
American Journal of Preventive Cardiology, Vol 6, Iss, Pp 100151-(2021)
American Journal of Preventive Cardiology
Summary Introduction Familial hypercholesterolaemia (FH) is a common, heritable and preventable cause of premature coronary artery disease, with significant potential for positive impact on public health and healthcare savings. New clinical practice
Autor:
Gerald F. Watts, David R. Sullivan, David L. Hare, Karam M. Kostner, Ari E. Horton, Damon A. Bell, Tom Brett, Ronald J. Trent, Nicola K. Poplawski, Andrew C. Martin, Shubha Srinivasan, Robert N. Justo, Clara K. Chow, Jing Pang, Zanfina Ademi, Justin J. Ardill, Wendy Barnett, Timothy R. Bates, Lawrence J. Beilin, Warrick Bishop, J. Andrew Black, Peter Brett, Alex Brown, John R. Burnett, Christina A. Bursill, Alison Colley, Peter M. Clifton, Elif I. Ekinci, Luke Elias, Gemma A. Figtree, Brett H. Forge, Jacquie Garton-Smith, Dorothy F. Graham, Ian Hamilton-Craig, Christian R. Hamilton-Craig, Clare Heal, Charlotte M. Hespe, Amanda J. Hooper, Laurence G. Howes, Jodie Ingles, John Irvin, Edward D. Janus, Nadarajah Kangaharan, Anthony C. Keech, Andrew B. Kirke, Leonard Kritharides, Campbell V. Kyle, Paul Lacaze, Kirsten Lambert, Stephen C.H. Li, Wynand Malan, Stjepana Maticevic, Brendan M. McQuillan, Sam Mirzaee, Trevor A. Mori, Allison C. Morton, David M. Colquhoun, Joanna C. Moullin, Paul J. Nestel, Kristen J. Nowak, Richard C. O'Brien, Nicholas Pachter, Michael M. Page, Annette Pedrotti, Peter J. Psaltis, Jan Radford, Nicola J. Reid, Elizabeth N. Robertson, Jacqueline D.M. Ryan, Mitchell N. Sarkies, Carl J. Schultz, Russell S. Scott, Christopher Semsarian, Leon A. Simons, Catherine Spinks, Andrew M. Tonkin, Frank van Bockxmeer, Kathryn E. Waddell-Smith, Natalie C. Ward, Harvey D. White, Andrew M. Wilson, Ingrid Winship, Ann Marie Woodward, Stephen J. Nicholls
Publikováno v:
Heart, lungcirculation. 30(3)
Familial hypercholesterolaemia (FH) is a dominant and highly penetrant monogenic disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL)-cholesterol concentration and, if untreated, leads to premature atherosclerosis a
Autor:
Edward D Janus, S. Mirzaee, David L Hare, Paul J. Nestel, Frank M. van Bockxmeer, Damon A. Bell, Timothy R. Bates, Leon A. Simons, John R. Burnett, Richard C O'Brien, David R. Sullivan, Warrick Bishop, Gerald F. Watts, Andrew Wilson, Karam Kostner, Justin J. Ardill, Jacqueline D.M. Ryan, Jing Pang, Peter M. Clifton, David Colquhoun, Dick C. Chan
Publikováno v:
Heart, lungcirculation. 30(3)
Background Familial hypercholesterolaemia (FH) is under-diagnosed and under-treated worldwide, including Australia. National registries play a key role in identifying patients with FH, understanding gaps in care and advancing the science of FH to imp
Autor:
Dimple Kauhanen, Wolfgang Koenig, Mitja Lääperi, John Simes, Paul J. Nestel, Ottar Nygård, Ben Schöttker, Hermann Brenner, Reijo Laaksonen, Mika Hilvo, David R. Sullivan, Eva Ringdal Pedersen, Natalie A. Mellett, Peter J. Meikle, Antti Jylhä, Dietrich Rothenbacher, Kevin Huynh, Andrew Tonkin, Grethe S. Tell, Indu Dhar, Kaisa M. Koistinen
Publikováno v:
Hilvo, M, Meikle, P J, Pedersen, E R, Tell, G S, Dhar, I, Brenner, H, Schöttker, B, Lääperi, M, Kauhanen, D, Koistinen, K M, Jylhä, A, Huynh, K, Mellett, N A, Tonkin, A M, Sullivan, D R, Simes, J, Nestel, P, Koenig, W, Rothenbacher, D, Nygård, O & Laaksonen, R 2020, ' Development and validation of a ceramide-And phospholipid-based cardiovascular risk estimation score for coronary artery disease patients ', European Heart Journal, vol. 41, no. 3, pp. 371-380 . https://doi.org/10.1093/eurheartj/ehz387
Journal of Heart Failure
Journal of Heart Failure
Aims Distinct ceramide lipids have been shown to predict the risk for cardiovascular disease (CVD) events, especially cardiovascular death. As phospholipids have also been linked with CVD risk, we investigated whether the combination of ceramides wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05d82e120fdc0f25a2d9618daf3da8bd
https://cris.vtt.fi/en/publications/e4efcd39-4a58-48ce-a1e9-c8c1058be26d
https://cris.vtt.fi/en/publications/e4efcd39-4a58-48ce-a1e9-c8c1058be26d